New drug B001 aims to tame rare nerve disease in early trial
NCT ID NCT05145361
First seen May 07, 2026 · Last updated May 08, 2026 · Updated 1 time
Summary
This early-stage study is testing an experimental drug called B001 in 45 adults with a specific type of neuromyelitis optica spectrum disorder (NMOSD), a rare autoimmune disease that attacks the optic nerve and spinal cord. Participants must have had at least one relapse in the past year and test positive for AQP4 antibodies. The main goals are to check the drug's safety and how the body processes it, while also looking for early signs that it might help control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NMO SPECTRUM DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Tiantan Hospital Capital Medical University
RECRUITINGBeijing, Beijing Municipality, 100050, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
First Hospital of Shanxi Medical University
RECRUITINGTaiyuan, Shanxi, 030001, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Tangdu hospital,fourth military medical university
RECRUITINGXi’an, Shanxi, 710038, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Tianjin Medical University General Hospital
RECRUITINGTianjin, Tianjin Municipality, 300052, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.